Participation of the receptor for advanced glycation end products in efferocytosis

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6191-6198

  Friggeri, Arnaud ^a,b,c   Banerjee, Sami ^c   Biswas, Subrata ^c   De Freitas, Andressa ^c   Liu, Gang ^c   Bierhaus, Angelika ^d   Abraham, Edward ^c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PHOSPHATIDYLSERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL INTERACTION; CELL ISOLATION; CELL METABOLISM; EFFEROCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LUNG CAVITY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYMOCYTE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; HEK293 CELLS; HUMANS; INTERLEUKIN-10; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTES; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; RECEPTORS, IMMUNOLOGIC; THYMUS GLAND;

EID: 79958032955     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004134     Document Type: Article

References (36)

1. Haslett, C. 1999. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med. 160: S5-S11.
2. high regulatory phenotype in macrophages. J. Immunol. 185: 2044-2050.
3. Baumann, I., W. Kolowos, R. E. Voll, B. Manger, U. Gaipl, W. L. Neuhuber, T. Kirchner, J. R. Kalden, and M. Herrmann. 2002. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46: 191-201. (Pubitemid 34121664)
4. Schmidt, A. M., S. D. Yan, S. F. Yan, and D. M. Stern. 2000. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498: 99-111.
5. Su, X., M. R. Looney, N. Gupta, and M. A. Matthay. 2009. Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L1-L5.
6. Liu, G., J. Wang, Y. J. Park, Y. Tsuruta, E. F. Lorne, X. Zhao, and E. Abraham. 2008. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J. Immunol. 181: 4240-4246.
7. Banerjee, S., A. Friggeri, G. Liu, and E. Abraham. 2010. The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. J. Leukoc. Biol. 88: 973-979.
8. 3-integrin. Am. J. Physiol. Cell Physiol. 299: C1267-C1276.
9. Hanayama, R., M. Tanaka, K. Miwa, A. Shinohara, A. Iwamatsu, and S. Nagata. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-187. (Pubitemid 34506799)
10. Yang, Y., A. Friggeri, S. Banerjee, K. Bdeir, D. B. Cines, G. Liu, and E. Abraham. 2010. Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils. Am. J. Respir. Crit. Care Med. 182: 1516-1523.
11. Rodriguez-Manzanet, R., M. A. Sanjuan, H. Y. Wu, F. J. Quintana, S. Xiao, A. C. Anderson, H. L. Weiner, D. R. Green, and V. K. Kuchroo. 2010. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc. Natl. Acad. Sci. USA 107: 8706-8711.
12. Neeper, M., A. M. Schmidt, J. Brett, S. D. Yan, F. Wang, Y. C. Pan, K. Elliston, D. Stern, and A. Shaw. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
13. Schlueter, C., S. Hauke, A. M. Flohr, P. Rogalla, and J. Bullerdiek. 2003. Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing? Biochim. Biophys. Acta 1630: 1-6. (Pubitemid 37297971)
14. Raucci, A., S. Cugusi, A. Antonelli, S. M. Barabino, L. Monti, A. Bierhaus, K. Reiss, P. Saftig, and M. E. Bianchi. 2008. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22: 3716-3727.
15. Sternberg, D. I., R. Gowda, D. Mehra, W. Qu, A. Weinberg, W. Twaddell, J. Sarkar, A. Wallace, B. Hudson, F. D'Ovidio, et al. 2008. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J. Thorac. Cardiovasc. Surg. 136: 1576-1585.
16. Liliensiek, B., M. A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H. J. Gröne, F. C. Kurschus, A. M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113: 1641-1650.
17. Aleshin, A., R. Ananthakrishnan, Q. Li, R. Rosario, Y. Lu, W. Qu, F. Song, S. Bakr, M. Szabolcs, V. D'Agati, et al. 2008. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. Am. J. Physiol. Heart Circ. Physiol. 294: H1823-H1832.
18. Zhang, H., S. Tasaka, Y. Shiraishi, K. Fukunaga, W. Yamada, H. Seki, Y. Ogawa, K. Miyamoto, Y. Nakano, N. Hasegawa, et al. 2008. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 178: 356-362.
19. Ravichandran, K. S. 2010. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J. Exp. Med. 207: 1807-1817.
20. Miyanishi, M., K. Tada, M. Koike, Y. Uchiyama, T. Kitamura, and S. Nagata. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature 450: 435-439. (Pubitemid 350126753)
21. Koch, M., S. Chitayat, B. M. Dattilo, A. Schiefner, J. Diez, W. J. Chazin, and G. Fritz. 2010. Structural basis for ligand recognition and activation of RAGE. Structure 18: 1342-1352.
22. Koopman, G., C. P. Reutelingsperger, G. A. Kuijten, R. M. Keehnen, S. T. Pals, and M. H. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420. (Pubitemid 24273007)
23. Freeman, G. J., J. M. Casasnovas, D. T. Umetsu, and R. H. DeKruyff. 2010. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev. 235: 172-189.
24. Park, D., A. C. Tosello-Trampont, M. R. Elliott, M. Lu, L. B. Haney, Z. Ma, A. L. Klibanov, J. W. Mandell, and K. S. Ravichandran. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450: 430-434.
25. Park, S. Y., M. Y. Jung, H. J. Kim, S. J. Lee, S. Y. Kim, B. H. Lee, T. H. Kwon, R. W. Park, and I. S. Kim. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15: 192-201.
26. Yan, S. F., R. Ramasamy, and A. M. Schmidt. 2010. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem. Pharmacol. 79: 1379-1386.
27. Bopp, C., A. Bierhaus, S. Hofer, A. Bouchon, P. P. Nawroth, E. Martin, and M. A. Weigand. 2008. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 12: 201.
28. Creagh-Brown, B. C., G. J. Quinlan, T. W. Evans, and A. Burke-Gaffney. 2010. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med. 36: 1644-1656.
29. Yan, S. F., R. Ramasamy, and A. M. Schmidt. 2009. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert Rev. Mol. Med. 11: e9.
30. Munoz, L. E., K. Lauber, M. Schiller, A. A. Manfredi, and M. Herrmann. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6: 280-289.
31. Uchida, T., M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z. A. Matthay, and M. A. Matthay. 2006. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 173: 1008-1015.
32. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901. (Pubitemid 29375048)
33. Mevorach, D., J. O. Mascarenhas, D. Gershov, and K. B. Elkon. 1998. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188: 2313-2320.
34. Wang, Y., H. Wang, M. G. Piper, S. McMaken, X. Mo, J. Opalek, A. M. Schmidt, and C. B. Marsh. 2010. sRAGE induces human monocyte survival and differentiation. J. Immunol. 185: 1822-1835.
35. Hudson, B. I., A. Z. Kalea, M. Del Mar Arriero, E. Harja, E. Boulanger, V. D'Agati, and A. M. Schmidt. 2008. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J. Biol. Chem. 283: 34457-34468.
36. Ishihara, K., K. Tsutsumi, S. Kawane, M. Nakajima, and T. Kasaoka. 2003. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett. 550: 107-113. (Pubitemid 37281366)